Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export price history as CSV.

Makers Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: MAKERSL BSE: 506919
₹181.75
▲ 0.37 (0.20%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
59/100
Moderate
Valuation
100/100
Undervalued
Momentum
54/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹107 Cr
PE (TTM)
Data unavailable.
Price to Book
0.9
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹11 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-295.65%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
0.00%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-0.87%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
912.23%
as of Sept. 30, 2024
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-25.78%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
2.56
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.04
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
-4.26
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
69.83%
as of Sept. 30, 2024
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-11.00%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-5.14%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
4.50%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-2.66%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
6.08%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.04)
  • No Return on equity is 15% or more (6.1%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 2 met
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 4 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.2%
Low 178.0000 · High 189.4900
1W return
-0.6%
Low 178.0000 · High 192.9900
1M return
-1.9%
Low 171.3600 · High 206.8500
52W return
Data unavailable.
Low 150.0000 · High 236.0000
Lifetime High ₹220.8600 (Aug. 24, 2026)
Lifetime Low ₹152.5900 (Aug. 17, 2026)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish3
5D
183.1
10D
183.9
20D
185.1

Delivery and volume

Day avg. delivery
90.8%
Week avg. delivery
87.4%
Month avg. delivery
76.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

183.08
Pivot
First resistance188.16
Second resistance194.57
Third resistance199.65
First support176.67
Second support171.59
Third support165.18
Day RSI54.0
Day MFI37.7
Day MACD—
Day MACD signal—

Beta

1M1.40
3M1.42
1Y1.42
3Y1.42

Price change analysis

↓ -1.9%
Over 1 Month
LowHigh
171.36206.85
—
Over 3 Months
LowHigh
150.00236.00
—
Over 6 Months
LowHigh
150.00236.00
—
Over 1 Year
LowHigh
150.00236.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹10 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹-1.8200

Ranks #138 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter61.27%

Largest holders

NameCategoryShares %Shares
Kaygee Investments Private LimitedPromoter36.8800%2175859
Kaygee Laboratories Private LimitedPromoter14.3500%846720
Investor Educatin & Protection Fund (IEPF)Public2.8400%167305
Tanvi Jignesh MehtaPublic2.2900%135254
Premchand GodhaPromoter2.1500%127033

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 61.27% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
20 May 2026 USHA JAWAHARLAL KALRO Bulk Sell 26,158 180.2500 BSE
20 May 2026 USHA JAWAHARLAL KALRO Bulk Buy 31,009 173.2700 BSE
13 Mar 2023 MANJU SINGHI Bulk Sell 29,562 105.7500 BSE
23 Nov 2020 VINAR NIRYAT PRIVATE LIMITED Bulk Buy 46,250 138.7600 BSE
23 Nov 2020 VARA LAKSHMI G Bulk Sell 59,149 139.5000 BSE
6 Oct 2020 NEELIMA KARLAPUDI Bulk Sell 50,236 96.9000 BSE
12 Aug 2020 USHA ASHOK SAMANI Bulk Buy 30,000 72.7000 BSE
3 Aug 2020 GUTTIKONDA VARA LAKSHMI Bulk Sell 24,991 79.2300 BSE
8 Apr 2020 NANDA DEVI INVESTMENTS Bulk Sell 25,977 39.9500 BSE
21 Sep 2018 GUTTIKONDA VARA LAKSHMI Bulk Buy 30,771 99.0400 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
10 Sep 2026 AGM/EGM Makers Laboratories Ltd-$ - 506919 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (69.8%)
  • Low financial leverage (Debt/Equity 0.04)
  • Healthy liquidity (Current Ratio 2.56)

Weaknesses

  • Low Return on Equity (6.1%)
  • Declining revenue YoY (-25.8%)

Opportunities

  • Trading below book value (PB 0.88)

Threats

  • Weak interest coverage (-4.3x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Makers Laboratories Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.